NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for Patents Actions


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
AvidBiotics Corp. Granted Key U.S. and European Patents on Unique Protein Modification Platform
2009 NOV 23 ... Proteomics, Deoxyribonucleic Acid, Genetics, Marketing and Licensing Agreements, Patents Actions, Protein Encoding, Protein Therapies, Proteomics, Therapy, Treatment, Avidbiotics Corp. ...
Subject: Marketing and Licensing Agreements
Price: $3.00
*
Cerimon Pharmaceuticals Acquires European Rights to its Topical Diclofenac Sodium Patch
2009 NOV 23 ... Clinical Trial Research, Cyclooxygenase Inhibitor, Diclofenac, NSAID, Pain Management, Patents Actions, Pharmaceuticals, Soft Tissue Injuries, Therapy, Treatment, Cerimon Pharmaceuticals Inc. ...
Subject: Pharmaceuticals
Price: $3.00
*
Chlor*Rid Announces Soluble Salt Remover is 100% Green
2009 NOV 18 ... at: http://www.thomas-pr.com/pr/chlorridgreen.html Keywords: Life Sciences, Patents Actions. This article was prepared by Medical Patent Law Weekly editors from staff ...
Subject: Life Sciences
Price: $3.00
*
Depomed Receives Notice of Paragraph IV Certification Against Patents for GLUMETZA(R)
2009 NOV 23 ... Legal, Technology, Biotechnology, Drug Development, FDA, Hypoglycemic Agent, Metformin, Patents Actions, Regulatory Actions, Therapy, Treatment, U.S. Food and Drug Administration, Depomed Inc. ...
Subject: Depomed, Inc.
Price: $3.00
*
Endo Pharmaceuticals and LecTec Settle Patent Dispute
2009 NOV 23 ... legal officer of Endo Pharmaceuticals. Keywords: Endo Pharmaceuticals Inc., Patents Actions, Pharmaceutical Business, Pharmaceutical Company, Therapy, Treatment. This ...
Subject: Pharmaceuticals
Price: $3.00
*
Fighting Healthcare Associated Infections HAIs With New Ceiling Lift Technology by T.H.E. Medical
2009 NOV 24 ... Infectious Diseases, Medical Devices, Technology, H1N1 Virus, Infectious Disease, Patents Actions, Swine Flu, Swine Influenza. This article was prepared by Health Risk ...
Subject: T.H.E. Medical
Price: $3.00
*
Former Pfizer Global R&D President John LaMattina Joins PureTech Ventures as Senior Partner; PureTech Announces Partner Promotions
2009 NOV 23 ... Drug Discovery, Drugs, Erlotinib Hydrochloride, Lyrica, Merck & Company Inc., Oncology, Patents Actions, Pfizer, Pharmaceutical Business, Pharmaceutical Company, Pharmaceuticals, Pharmacia, ...
Subject: Diabetes
Price: $3.00
*
Glenbrook Technologies wins Edison Award and Invention Advancement Award
2009 NOV 24 ... or visit www.glenbrooktech.com. Keywords: Life Sciences, Patents Actions, Diagnosis, Diagnostics. This article was prepared by Life Science Weekly ...
Subject: Life Sciences
Price: $3.00
*
LecTec Corporation and Endo Pharmaceuticals Inc. Settle Patent Dispute
2009 NOV 23 ... Endo Pharmaceuticals Inc., Marketing and Licensing Agreements, Pain Medicine, Patents Actions, Pharmaceutical Business, Pharmaceutical Company, Therapy, Treatment, LecTec ...
Subject: LecTec Corporation
Price: $3.00
*
ModiFace Announces Breakthrough in Eyelash and Hair Simulation Technology
2009 NOV 24 ... info@modiface.com for further information. Keywords: ModiFace, Inc., Patents Actions, Weight Loss, Aging This article was prepared by Life Science Weekly ...
Subject: ModiFace, Inc.
Price: $3.00
*
QRxPharma Inks Deal with Patheon for the Manufacture of MoxDuoCR
2009 NOV 23 ... Agreements, Neurology, Neurosurgery, Oncology, Osteoarthritis, Pain Management, Patents Actions, Pharmaceuticals, Pharmacokinetics, Regulatory Actions, Therapy, Treatment. ...
Subject: Biotech Business
Price: $3.00
*
Research from University of Leuven has provided new information about social science
2009 NOV 26 ... City:Louvain, Country:Belgium, City:Louvain, Country:Belgium, Life Sciences, Patents Actions, Social Science, University of Leuven.This article was prepared by Politics ...
Subject: Social Science
Price: $3.00
*
Ryogen is Awarded New Patent
2009 NOV 23 ... Diabetes, Diagnostics, Genetics, Inflammation, Metabolic Bone Disease, Obesity, Patents Actions, Protein Encoding, Proteomics, Ryogen LLC. This article was prepared by ...
Subject: Ryogen LLC
Price: $3.00
*
Salix Pharmaceuticals Reports 3Q2009 Results
2009 NOV 23 ... intellectual property position. "In recent weeks, two additional patents relating to rifaximin were issued by the U.S. Patent and Trademark Office. One patent ... Disorder, Gastroparesis, Metoclopramide Hydrochloride, Pharmaceuticals, Regulatory Actions, Rifaximin, Therapy, Treatment, U.S. Food and Drug Administration, Xifaxan, Salix ...
Subject: Salix Pharmaceuticals, Ltd.
Price: $3.00
*
Steady State Imaging Signs Reseller's Agreement With Varian, Inc.
2009 NOV 23 ... Keywords: Varian, Inc., Steady State Imaging, Llc, Cancer, Oncology, Patents Actions, Cancer Detection, Medical Device, Magnetic Resonance, Clinical Research, Bone. ...
Subject: Varian, Inc.; Steady State Imaging, Llc
Price: $3.00
*
Teva Files Amended Complaint Against Momenta/Sandoz to Include Infringement of Three COPAXONE(R)-Related Patents
2009 NOV 23 ... Professional Services, Legal, Drugs, Glatiramer Acetate, Momenta Pharmaceuticals, Patents Actions, Pharmaceutical Business, Pharmaceutical Company, Teva Pharmaceutical Industries Ltd., ...
Subject: Teva Pharmaceutical Industries Ltd.
Price: $3.00
*
Teva Receives Final Approval for Generic Prevacid(R) Delayed-Release Capsules
2009 NOV 23 ... products, especially Copaxone® sales, dependence on the effectiveness of our patents and other protections for innovative products, the impact of consolidation of our ... Pharmaceutical Business, Pharmaceutical Company, Pharmaceuticals, Regulatory Actions, Tap Pharmaceutical Products Inc., Teva Pharmaceutical Industries Ltd., Therapy, ...
Subject: Teva Pharmaceutical Industries Ltd.
Price: $3.00
*
Transcept Pharmaceuticals Reports Third Quarter 2009 Financial Results
2009 NOV 23 ... FDA, Hypnotics and Sedatives, Marketing and Licensing Agreements, Neuroscience, Patents Actions, Pharmaceutical Business, Pharmaceutical Company, Pharmaceuticals, Purdue Pharma LP, ...
Subject: Pharmaceuticals
Price: $3.00
*
U.S. Patent Office Issues Vermillion Patent for Biomarkers Detecting Ovarian Cancer
2009 NOV 23 ... Keywords: Diagnostics, Gynecology, Oncology, Ovarian Cancer, Ovarian Carcinoma, Patents Actions, Women's Health, Vermillion Inc. This article was prepared by Clinical ...
Subject: Ovarian Cancer
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login